Table 2.
Polymorphisms | HR | 95% CI | p-value |
---|---|---|---|
Myocardial infarction (n=274) | |||
Gly16Arg | 1.06 | 0.89−1.27 | 0.50 |
Gln27Glu | 1.08 | 0.91−1.28 | 0.39 |
Thr164Ile | 0.92 | 0.44−1.92 | 0.83 |
Ischemic stroke (n=299) | |||
Gly16Arg | 1.07 | 0.90−1.26 | 0.46 |
Gln27Glu | 0.85 | 0.72−1.00 | 0.06 |
Thr164Ile | 1.03 | 0.54−1.96 | 0.92 |
Death due to cardiovascular disease (n=159) | |||
Gly16Arg | 0.93 | 0.74−1.18 | 0.55 |
Gln27Glu | 1.02 | 0.82−1.28 | 0.86 |
Thr164Ile | 1.11 | 0.47−2.62 | 0.82 |
adjusting for: age, body mass index, history of hypertension, diabetes, physical activity, smoking categories, alcohol consumption, postmenopausal hormone use, oral contraceptive use, family history of myocardial infarction before age 60, and randomized aspirin assignment.